TSC
LUCD icon

Two Seas Capital’s Lucid Diagnostics LUCD Stock Holding History

Two Seas Capital’s Portfolio LUCD Stock Details LUCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.42M Buy
6,000,000
+3,000,000
+100% +$3.23M 0.13% 41
2026
Q1 		$3.45M Hold
3,000,000
– – 0.05% 43
2025
Q4 		$3.27M Hold
3,000,000
– – 0.07% 36
2025
Q3 		$3.03M Buy
+3,000,000
New +$3.28M 0.05% 38

Other funds holding LUCD

Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MCM
Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
First Manhattan
First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Two Seas Capital's LUCD Position: Q2 2026 in Review

Two Seas Capital increased its Lucid Diagnostics (LUCD) stake by 100% in Q2 2026, buying an estimated $3.23M and bringing the position to 6,000,000 shares worth $6.42M. The position accounts for 0.13% of the portfolio, ranked #41.

Two Seas Capital first reported a position in LUCD in Q3 2025 and has held it in 4 quarters since. 116 funds tracked by Wall St. Rank hold LUCD as of Q2 2026.

  • Two Seas Capital held 6,000,000 shares of Lucid Diagnostics worth $6.42M as of Q2 2026.
  • Two Seas Capital bought 3,000,000 Lucid Diagnostics shares in Q2 2026, an estimated $3.23M.
  • Lucid Diagnostics made up 0.13% of Two Seas Capital's portfolio in Q2 2026, its #41 holding.
  • Two Seas Capital first reported a position in Lucid Diagnostics in Q3 2025 and has held it in 4 quarters since.
  • 116 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q2 2026.

Based on Two Seas Capital's 13F filing for Q2 2026, filed 12 Aug 2026.